What amount sold does FORE US Bio Inc. report in Form D filings?

The latest linked filings report $132.5M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was FORE US Bio Inc.'s most recent SEC filing?

FORE US Bio Inc.'s most recent Form D filing was on 2026-07-14.

How many investors does FORE US Bio Inc. have?

The most recent Form D filing lists 20 investor(s).

What type of securities does FORE US Bio Inc. offer?

FORE US Bio Inc.'s SEC Form D filings indicate equity offerings.

FORE US Bio Inc.

CIK: 0001990659·Biotechnology·PHILADELPHIA, PA·Corporation·Founded 2022

Reported Sold

$132,489,567

Total Filings

Identified Offerings

Last Filed

Jul 14, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jul 14, 2026Form D/A — Amendment

Reported sold: $70,410,173 · Target: $109,619,395

Rule 506(b)·20 investors

Changed: Reported amount sold, Offering target, Reported investors

May 15, 2025Form D — New notice

Reported sold: $37,443,239 · Target: $46,024,857

Rule 506(b)·9 investors

Aug 24, 2023Form D — New notice

Reported sold: $62,079,394 · Target: $122,561,289

Rule 506(b)·20 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

33%

Latest reported sold across 2 identified offerings

$132,489,567

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Chandra Leo

Related Person

Appears on 2 filings

Matthew Foy

Related Person

Appears on 2 filings

Erez Chimovits

Related Person

Appears on 2 filings

Dieter Weinand

Related Person

Appears on 2 filings

Kim Blackwell

Related Person

Appears on 2 filings

Roberto De Ponti

Related Person

Appears on 1 filing

Meenu Chhabra Karson

Related Person

Appears on 1 filing

William Hinshaw

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jul 14, 2026	Amendment	$109,619,395	$70,410,173	20
May 15, 2025	New	$46,024,857	$37,443,239	9
Aug 24, 2023	New	$122,561,289	$62,079,394	20

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

BioLattice Ophthalmics, Inc,

Biotechnology

Offering target: $3,310,000

Filed Oct 28, 2026